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Microcarriers are microspheres ranging from a few nanometers to some hundreds of 
micrometers. One thousand nanometers equal one micrometer which is roughly half a millionth 
of an inch. The advantages of using polymeric microcarriers include biodegradability, low 
toxicity, and slow release.  Microcarriers for drug delivery may be formed from two general 
classes of polymers: the first, polyesters such as poly(lactide-co-glycolide) (PLGA); then the 
second, polyolefins such as poly(meth)acrylates. PLGA microcarriers can successfully be 
synthesized through a double emulsion process using sonication. These polyesters degrade in 
vivo by hydrolysis of their ester backbone into nontoxic products, which are excreted by the 
kidneys. The ratio of lactide to glycolide in the PLGA polymers, the molecular weight and the 
terminal group of the PLGA polymer determine how fast drug release occurs. Carboxyl-
terminated PLGA polymers offer faster drug release compared to ester-terminated PLGA. The 
following provides two literature examples of how microcarriers for drug release will work. The 
first example, published in 2015 [1], investigated the potential of PLGA based nanocarriers as a 
novel strategy to enhance penetration of therapeutic molecules into white blood cells 
(macrophages) as a model for HIV infection. Following infection, HIV establishes reservoirs in 
macrophages that are inaccessible to optimal levels of antiviral drugs thus escaping the action of 
anti-HIV drugs; and thus may contribute to the rebound observed after antiretroviral treatment is 
stopped. To allow for more effective HIV treatment, stable polyester PLGA nanoparticles (NPs), 
about 180 nm in size, were prepared. Their capacity to transport an active molecule into the 
human macrophage cell line THP-1 using bovine serum albumin (BSA), a protein, as a proof-of-
concept compound was evaluated. It was shown that encapsulation of BSA into PLGA NPs 
increased leukocyte infiltration in vivo, suggesting that enhanced delivery and protection of the 
protein by the polymer nanocarrier occurred. The second example, published in 2005 [2], 
describes the use of microparticles made from Eudragit P-4135F, a pH sensitive polyacrylate, for 
the purpose of treating inflammatory bowel disease (IBD). Adding FK506, an 
immunosuppressant, anti-inflammatory drug, to the microparticles provided efficient selective 
colonic drug delivery to the inflamed gut tissue. The selective delivery of the FK506 was shown 
to improve efficiency and tolerability in treating IBD. The important aspect of the study was that 
the FK506 loaded microparticles were administered orally as well as subcutaneously, to infected 
rats, resulting in a betterment in both cases. This shows a promise that oral administration may 
work as well as subcutaneous application. A major explanation for this occurrence is that the 
Eudragit P-4135F polymer protected the encapsulated FK506 from the acidity of the stomach 
acids while releasing at a neutral pH. In vitro studies of FK506 release from Eudragit P-4135F 
polymer microparticles confirmed that explanation. This proposal aims at exploring the 
aforementioned types of microparticles in support of a potential interdisciplinary project between 
the medical school, biology, and chemistry. 
 
Christian worldview integration: The Christian Gospel is the message of “good news” for how 
God has reconciled his image bearers to himself by offering forgiveness through the life, death, 
and resurrection of Jesus Christ. Moreover, further pointing to the goodness of creation, in the 
incarnation of Jesus, the eternal Son of God became flesh. Those who are in Christ are to be 
working against the disorder that exists within the world. The benefits of polymeric nanoparticle 
medicine could change the view of medicine in third world countries, where medicine is 
expensive and scarce. The Bible tell us in Mark 16:15 to spread the gospel to the whole Earth. If 
a nanoparticle that can be developed, by Christian’s, that can be administered to those who have 
HIV one will be able to save their life, and the gospel can be shared with them. Also, there is 
design in making the nanoparticles. There are many steps that are performed in making a 
nanoparticle. Each step has a defined purpose in accomplishing the task of helping the 
nanoparticle become biocompatible. An average human cell has a membrane that is both 
hydrophilic and hydrophobic. This concept has to be integrated into our nanoparticle. We will 
use certain polymers, like PLGA and Eudragit P-4135F, and proteins, like BSA, to create the 
hydrophobic and hydrophilic components. God has given us a model, the cell, and has shown us 
that we are able to replicate this idea into a new technique for medicine. It is incredible that 
something that is classified as “nonliving” can form into an intelligent design to help God’s 
people.  
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